JPMorgan Healthcare Leaders ETF
Registrant
J.P. Morgan Exchange-Traded Fund Trust
Class ticker
Net Assets
$11,125,001
Holdings
43
Latest Report
Apr 30, 2026
Holdings · 43
Export CSV
Only this fund's positions in US-listed stocks Equibles tracks are shown. Other
holdings — bonds, foreign securities, and cash — aren't listed yet, so the positions
below are a fraction of the fund's
$11,125,001 in net assets.
| Holding | Symbol | Balance | Value | % of Fund | Side | Category | Open |
|---|---|---|---|---|---|---|---|
| Eli Lilly & Co. | LLY | 811 | $757,961 | 6.81% | Long | EC | |
| AbbVie, Inc. | ABBV | 3,464 | $732,012 | 6.58% | Long | EC | |
| Johnson & Johnson | JNJ | 3,001 | $689,780 | 6.20% | Long | EC | |
| UnitedHealth Group, Inc. | UNH | 1,751 | $648,710 | 5.83% | Long | EC | |
| Merck & Co., Inc. | MRK | 4,289 | $468,273 | 4.21% | Long | EC | |
| Bristol-Myers Squibb Co. | BMY | 6,427 | $389,412 | 3.50% | Long | EC | |
| Thermo Fisher Scientific, Inc. | TMO | 740 | $354,430 | 3.19% | Long | EC | |
| Intuitive Surgical, Inc. | ISRG | 719 | $329,022 | 2.96% | Long | EC | |
| CVS Health Corp. | CVS | 3,618 | $301,343 | 2.71% | Long | EC | |
| Regeneron Pharmaceuticals, Inc. | REGN | 344 | $243,229 | 2.19% | Long | EC | |
| Boston Scientific Corp. | BSX | 3,946 | $227,329 | 2.04% | Long | EC | |
| Vertex Pharmaceuticals, Inc. | VRTX | 510 | $217,964 | 1.96% | Long | EC | |
| Danaher Corp. | DHR | 1,184 | $211,877 | 1.90% | Long | EC | |
| Edwards Lifesciences Corp. | EW | 2,435 | $203,323 | 1.83% | Long | EC | |
| McKesson Corp. | MCK | 243 | $198,094 | 1.78% | Long | EC | |
| Stryker Corp. | SYK | 562 | $177,103 | 1.59% | Long | EC | |
| Cardinal Health, Inc. | CAH | 796 | $153,532 | 1.38% | Long | EC | |
| Centene Corp. | CNC | 2,739 | $147,057 | 1.32% | Long | EC | |
| Biogen, Inc. | BIIB | 764 | $144,610 | 1.30% | Long | EC | |
| Zoetis, Inc. | ZTS | 1,136 | $130,606 | 1.17% | Long | EC | |
| United Therapeutics Corp. | UTHR | 226 | $129,125 | 1.16% | Long | EC | |
| IQVIA Holdings, Inc. | IQV | 726 | $114,977 | 1.03% | Long | EC | |
| Spyre Therapeutics, Inc. | SYRE | 1,327 | $98,795 | 0.89% | Long | EC | |
| Apogee Therapeutics, Inc. | APGE | 1,152 | $95,489 | 0.86% | Long | EC | |
| Ionis Pharmaceuticals, Inc. | IONS | 1,257 | $93,973 | 0.84% | Long | EC | |
| CG oncology, Inc. | CGON | 1,304 | $87,029 | 0.78% | Long | EC | |
| Align Technology, Inc. | ALGN | 437 | $76,916 | 0.69% | Long | EC | |
| Immunome, Inc. | IMNM | 3,351 | $76,872 | 0.69% | Long | EC | |
| Dyne Therapeutics, Inc. | DYN | 4,266 | $74,868 | 0.67% | Long | EC | |
| Dexcom, Inc. | DXCM | 1,196 | $71,222 | 0.64% | Long | EC | |
| Neurocrine Biosciences, Inc. | NBIX | 533 | $70,180 | 0.63% | Long | EC | |
| Cigna Group (The) | CI | 231 | $67,124 | 0.60% | Long | EC | |
| Alumis, Inc. | ALMS | 2,446 | $60,392 | 0.54% | Long | EC | |
|
Nuvalent, Inc.
|
670703107 | 584 | $58,564 | 0.53% | Long | EC | |
| Bio-Techne Corp. | TECH | 843 | $46,635 | 0.42% | Long | EC | |
| Sionna Therapeutics, Inc. | SION | 1,201 | $46,479 | 0.42% | Long | EC | |
| Disc Medicine, Inc. | IRON | 636 | $41,944 | 0.38% | Long | EC | |
| Alnylam Pharmaceuticals, Inc. | ALNY | 112 | $34,663 | 0.31% | Long | EC | |
| Viridian Therapeutics, Inc. | VRDN | 2,323 | $31,314 | 0.28% | Long | EC | |
| Evommune, Inc. | EVMN | 1,260 | $29,988 | 0.27% | Long | EC | |
| Xenon Pharmaceuticals, Inc. | XENE | 535 | $29,981 | 0.27% | Long | EC | |
| HCA Healthcare, Inc. | HCA | 68 | $29,543 | 0.27% | Long | EC | |
| Genmab A/S | GMAB | 523 | $13,870 | 0.12% | Long | EC |